Glucose (original) (raw)
Latest News for: glucose
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under
Caledonian Record 09 Jun 2026
Advancing CNTY-813 as a potential functional cure in Type 1 ...
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
Napa Valley Register 09 Jun 2026
Findings highlight potential to expand oral GLP-1 RA treatment options for patients with type 2 diabetes and obesity ... .
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable ...
Nasdaq Globe Newswire 08 Jun 2026
PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ ... .
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 (Form 8-K) (Century Therapeutics Inc)
Public Technologies 08 Jun 2026
Islet performance in a glucose tolerance test demonstrated glucose normalization within 60 minutes in both edited and unedited islets.
sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety
PR Newswire 08 Jun 2026
The double-blind, randomized, crossover clinical study confirmed that sweelin® does not affect blood glucose, insulin and GLP-1 levels compared to stevia and dextrose in healthy adults ... Blood glucose, ...
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with ...
Ouachita Citizen 07 Jun 2026
New Study Highlights Potential of CGM to Help Patients Improve Diabetes Management in Primary Care Settings ... .
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
PR Newswire 06 Jun 2026
The trial evaluated the impact of CGM on blood glucose management and A1C levels (a way to understand blood glucose levels over the past two or three months) over 26 weeks ... blood glucose meter testing.
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
PR Newswire 05 Jun 2026
The study's primary endpoint was change in A1C, a measure of average blood glucose levels over the previous 2 to 3 months, from baseline to week 16 ... devices that track glucose levels in real time.
Glucose Health, Inc. (GLUC) Appoints Gerry David as Chairman of Strategic Advisory Board of Directors
Nasdaq Globe Newswire 04 Jun 2026
Former Celsius Holdings (CELH) CEO Gerry David to Support Growth and Business Development Initiatives of Glucose Health. Former Celsius Holdings (CELH) CEO Gerry David to Support Growth and Business Development Initiatives of Glucose Health ... .
[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a ...
Nasdaq Globe Newswire 04 Jun 2026
Non-invasive blood glucose monitoring devices market size to reach 340.49Mnby2034from340.49 Mn by 2034 from 340.49Mnby2034from34.86 Mn in 2024, at a CAGR of 25.60% ... .
What leg exercises actually do to your blood glucose: ‘Up to 52%…’
Indian Express 03 Jun 2026
Even short daily routines can contribute positively to blood sugar control when done consistently. .
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
Canada Newswire 03 Jun 2026
MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing dual glucose-ketone sensors designed to integrate exclusively with MiniMed smart dosing systems.
You don't have to cut out sugar to avoid glucose spikes? Biochemist shares how to ...
Hindustan Times 02 Jun 2026
Dexcom alerts users after faulty G7 glucose sensors stolen and resold
Penn Live 01 Jun 2026
People with diabetes who use the Dexcom G7 continuous glucose monitoring system need to check the lot numbers on sensors ....
Dabur Glucose launches ‘Energize India’ campaign to promote young athletes in major sports academies
The Times of India 30 May 2026